KRAS and colorectal carcinoma: Among the subgroup of Caucasians with stage IV CRC, KRAS-mutant CRC was associated with a worse OS than KRAS-WT CRC (19 vs. 33 months), with the difference approaching statistical significance (p = 0.053).